Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > .01 by next week
View:
Post by billybuk on Feb 11, 2021 1:30pm

.01 by next week

.01$ next week then they will let's trade lol
Comment by Bvukmanic on Feb 11, 2021 3:54pm
Is it true they have $25 million grant for R107? Saw it on the new website.
Comment by Moonshiner592 on Feb 11, 2021 4:14pm
  If my memory serves me right - It said "To date we have received  $25 million dollars from BARDA for R107 AND R100 (for CILi)
Comment by Bvukmanic on Feb 11, 2021 4:28pm
You're right. Too bad, thought they had something to work with.
Comment by indaknownewfie on Feb 11, 2021 7:51pm
Thats what I read too. This is already money that the Salzman group has expended getting R-107 to this point. Not a new 25 million. 
Comment by Bvukmanic on Feb 11, 2021 9:04pm
Already been confirmed. I had only seen their home page which said "$25 million in research funding" and recall from their slide deck that $15m had been spent on CILI. I guess the difference came from NIH that wasn't mentioned. Salzman has an incredible ability to blow through other peoples money - like giving talent $13 million in cash. $25 million and didn't even reach a ...more  
Comment by Captainblk on Feb 11, 2021 4:18pm
from what I remember, the verbage is a little questionable- it doesnt explicitly say they are receving that kind of injection or if they have historically received that kind of dollar amount over the last X tmie period.  basically, it needs a proper NR to clairify whats up
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities